A Study Of Stellate Ganglion Blockade With Liposomal Bupivacaine In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery
Effectiveness Of Liposomal Bupivacaine Stellate Ganglion Blockade In Preventing Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery: A Randomized Placebo-Controlled Trial
The purpose of this study is assess the incidence of postoperative atrial fibrillation (POAF) within one week of surgery in patients who receive pre-surgical stellate ganglion blockade with liposomal bupivacaine, compared to those receiving a saline placebo, using continuous electrocardiographic monitoring via wearable ECG devices.
調査の概要
研究の種類
入学 (推定)
段階
- フェーズ 4
連絡先と場所
研究連絡先
- 名前:Anesthesia Clinical Research Unit (ACRU) Study Team
- 電話番号:866-265-9263
- メール:ripollsanz.juan@mayo.edu
研究場所
-
-
Minnesota
-
Rochester、Minnesota、アメリカ、55905
- 募集
- Mayo Clinic in Rochester
-
コンタクト:
- ACRU Study Team
- 電話番号:866-265-9263
-
主任研究者:
- Juan G. Ripoll Sanz, MD
-
副調査官:
- Erica Wittwer, MD,PhD
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Adults aged ≥40 years scheduled to undergo isolated coronary artery bypass grafting will be eligible. Robotic CABG procedures are allowed.
- Cases will also remain eligible if, after the initial surgical listing, additional procedures-such as valvular interventions or septal myectomy-are performed, OR if CABG is listed as the primary intervention with other procedures noted as possible additional interventions.
- Cases will remain eligible if left atrial appendage ligation is concomitantly listed with the CABG.
Exclusion criteria:
- History of Permanent atrial fibrillation (paroxysmal, persistent or permanent),
- Mechanical circulatory support implant or explant
- Heart and/or lung transplant patients
- Active infection/sepsis
- Pre-operative anti-arrhythmic use (aside from beta-blockers).
- MAZE procedures, pulmonary vein isolation or cryotherapy will exclude patients if concomitantly listed with the CABG.
- Participant has a known allergy to adhesives or hydrogels.
- Participant has a visible skin injury or broken skin at the location for study device placement.
- Participant does not have the competency to wear the device for the prescribed patching period.
- Participant has a neuro-stimulator, as it may disrupt the quality of ECG data.
- Participants who are pregnant. In accordance with Mayo Clinic's standard cardiac surgery protocol, all women of childbearing potential undergo routine preoperative pregnancy testing. Pregnancy status will therefore be confirmed prior to enrollment. Any participant with a positive pregnancy test will be deemed ineligible and will not be enrolled in the study.
- Participants who lack the capacity to provide informed consent will not be approached or enrolled in this study.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Stellate ganglion block using liposomal bupivacaine
10 mL of liposomal bupivacaine 133 mg (133 mg/10 ml or 1.33%) |
Patients undergoing isolated coronary artery bypass grafting will receive a stellate ganglion block using liposomal bupivacaine prior to surgery |
|
プラセボコンパレーター:Sham block using saline placebo
10 mL of saline placebo injected in the plane of the right stellate ganglion |
Patients undergoing isolated coronary artery bypass grafting will receive a saline placebo injection to the stellate ganglion prior to surgery |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Incidence of new-onset postoperative atrial fibrillation (POAF) within one week of isolated coronary artery bypass grafting (CABG) surgery
時間枠:1 week
|
Total number of patients to experience postoperative atrial fibrillation within one week of CABG surgery. |
1 week
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Total duration of postoperative atrial fibrillation (POAF) episodes within the first postoperative week
時間枠:1 week
|
Duration of postoperative atrial fibrillation episodes will assessed via continuous ECG monitoring and reported in minutes |
1 week
|
|
Number of patients with successful stellate ganglion blockade
時間枠:1 week
|
Success rate of the stellate ganglion blockade is defined as a ≥1.0°C increase in ipsilateral hand skin temperature from baseline and/or a reduction in skin sympathetic nerve activity (SKNA) as measured by noninvasive surface recordings pre- and post-block. |
1 week
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Juan G. Ripoll Sanz, MD、Mayo Clinic
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。